Whitehawk Therapeutics (AADI) Q2 2023 Earnings

9AugConfirmed
Aug 22
Nov 22
Q1 2023
Q2 2023
-0.87
-0.77
-0.67
-0.57

Details

Expected EPS
-0.62
Actual EPS
-0.67
Surprise EPS
-0.05
Surprise Percent
+8.06%

Description

Whitehawk Therapeutics (AADI) has reported earnings of -0.67 per share for Q2 2023.

0 Comments

Share your thoughts